Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Ítems similars

• Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease
  per: Balakrishnan, Vijayakumar, et al.
  Publicat: (2020)
• Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
  per: Valentina L. Kouznetsova, et al.
  Publicat: (2020-09-01)
• Repurposing of FDA-approved drugs against cancer – focus on metastasis
  per: Ozsvári, Béla, et al.
  Publicat: (2016)
• In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
  per: Gurung, Arun Bahadur, et al.
  Publicat: (2020)
• A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease
  per: Mandour, Yasmine M., et al.
  Publicat: (2020)